Moderna

News

Moderna nears COVID-19 vaccine finish line as it wraps up st...

Moderna is close to completing its phase 3 trial of COVID-19 vaccine candidate mRNA-1273 after completing recruitment of the 30,000 subjects in the trial.

News

"Tokyo, Japan - May 11, 2012: Pfizer building on May 11, 2012 in Tokyo. Pfizer is one of largest pharmaceutical companies worldwide with tremendous revenue $67.4 bn USD for 2011. It exists since 1849."

Pfizer to wait until after election to file COVID-19 vaccine...

Pfizer said it will wait until after the US election to file its COVID-19 vaccine with the US regulator, as it awaits important safety data to become available.

News

Moderna broadens R&D scope with Vertex, Chiesi alliances

All eyes may be on Moderna’s COVID-19 vaccine at the moment, but the US biotec

News

AZ halts COVID-19 vaccine after safety scare, as UK faces 's...

It’s a bleak day in the fight against COVID-19, after the UK banned social gatherings of more than six people to contain growing numbers of new cases and the lead vaccine trial from AstraZe

News

COVID-19 vaccine could be ready in time for US elections

Health officials in the US have been told to prepare for a COVID-19 vaccine to be ready by November ahead of the US presidential elections, according to press reports.

News

Moderna’s COVID vaccine works in older people, according to ...

Moderna has said that its coronavirus vaccine stimulated an immune response in older people in phase 1 trials, suggesting that the jab is effective in the age groups most susceptible to COVID-19

Moderna nears COVID-19 vaccine finish line as it wraps up st...

Pfizer to wait until after election to file COVID-19 vaccine...

Moderna broadens R&D scope with Vertex, Chiesi alliances

AZ halts COVID-19 vaccine after safety scare, as UK faces 's...

COVID-19 vaccine could be ready in time for US elections

Moderna’s COVID vaccine works in older people, according to ...

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Moderna

Editor's Picks